ArticleCancer control : journal of the Moffitt Cancer Center

Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Camrelizumab Compared With Conventional Transarterial Chemoembolization Plus Camrelizumab for Unresectable Hepatocellular Carcinoma.

Yanqiao Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.